Globus Medical (GMED) vs. Its Rivals Financial Contrast

Globus Medical (NYSE: GMED) is one of 91 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it compare to its rivals? We will compare Globus Medical to related companies based on the strength of its valuation, profitability, risk, analyst recommendations, dividends, earnings and institutional ownership.

Insider and Institutional Ownership

65.5% of Globus Medical shares are held by institutional investors. Comparatively, 68.2% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by institutional investors. 28.2% of Globus Medical shares are held by company insiders. Comparatively, 11.3% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Globus Medical and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Globus Medical 17.54% 13.67% 12.35%
Globus Medical Competitors -4,427.32% -38.16% -9.82%

Volatility & Risk

Globus Medical has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, Globus Medical’s rivals have a beta of 1.09, indicating that their average stock price is 9% more volatile than the S&P 500.

Valuation and Earnings

This table compares Globus Medical and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
Globus Medical $563.99 million $104.34 million 32.67
Globus Medical Competitors $1.09 billion $127.65 million 196.26

Globus Medical’s rivals have higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of recent recommendations for Globus Medical and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Globus Medical 1 4 6 0 2.45
Globus Medical Competitors 213 1309 2854 101 2.64

Globus Medical presently has a consensus target price of $34.00, indicating a potential downside of 5.40%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 5.81%. Given Globus Medical’s rivals stronger consensus rating and higher possible upside, analysts plainly believe Globus Medical has less favorable growth aspects than its rivals.

Summary

Globus Medical rivals beat Globus Medical on 9 of the 13 factors compared.

About Globus Medical

Globus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company’s products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company sells its products through exclusive sales force in the United States, as well as within North, Central & South America, Europe, Asia, Africa and Australia. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.

Receive News & Ratings for Globus Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globus Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply